Mono Pharmacare MD, chairman, board of directors and AGM

NSE: MONOPHARMAPharmaceuticals & Biotechnology

Last close ₹8.50down ₹0.40 (4.49%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹8.90.

52-week range of traded prices to 23 Oct 2026
₹7.50Low, 10 Aug 2026₹22.05High, 28 Nov 2025
Market cap
₹15 Cr
P/E
42.4
P/B
0.5
Dividend yield
Nonein the last 12 months
ROE
1.1%
Debt to equity
1.79
Volume, NSE
2,000100.0% delivered

Mono Pharmacare board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.

    An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

    Statutory auditor

    Named in the results for the quarter to Mar 2026.

    • M/s. R. K. Mergu & Co.Peer-review certificate valid to Jun 2027
    1 earlier auditor
    • KUMBHAT & CO. LLPNamed in filings from Mar 2025 to Sep 2025

    A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

    Mono Pharmacare AGM and shareholder votes

    Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Mono Pharmacare share news and announcements

    Annual general meeting, 30 Sep 2026

    546 shareholders on the register on 23 Sep 2026; present: 4 promoters and 3 others; votes counted by ANKITA SURANA / SURANA AND KOTHARI ASSOCIATES LLP.The company's voting result (opens in a new tab)

    1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereon.MoreLess
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · other public 0.00%

      Turnout: all 56.81% · promoters 99.99% · other public 0.14%

    2. To appoint a Director in place of Mr. PANILAM LAKHATARIYA (DIN: 07659275), who retires by rotation and being eligible, offers himself for re-appointment:
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · other public 0.00%

      Turnout: all 56.81% · promoters 99.99% · other public 0.14%

    3. To appoint the M/s R K Mergu and Co. Chartered Accountants, (FRN: 136876W) as a Statutory Auditor of the company.
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · other public 0.00%

      Turnout: all 56.81% · promoters 99.99% · other public 0.14%

    4. Approval of related party transactions to be entered into for F.Y. 2026-27.
      OrdinaryPromoters have an interest in it
      100.00% for0.00% against

      Against: promoters 0.00% · other public 0.00%

      Turnout: all 0.06% · promoters 0.00% · other public 0.13%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Extraordinary general meeting, 30 Jun 2026, 2 resolutions

    546 shareholders on the register on 23 Jun 2026; present: 2 promoters and 5 others; votes counted by ANKITA SURANA / SURANA AND KOTHARI ASSOCIATES LLP.The company's voting result (opens in a new tab)

    1. Appointment of Statutory Auditor to fill the Casual Vacancy
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 56.96% · promoters 100.00% · institutions 0.00% · other public 0.56%

    2. Appointment of Ms. Nirmala Ranawat (DIN: 11309088) as Independent Director
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 56.96% · promoters 100.00% · institutions 0.00% · other public 0.56%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Investor complaints and compliance

    Quarter by quarter.

    Investor complaints received and resolved, the company's own count

    • Received
    • Resolved

    Open at the quarter's end

    None open at any quarter's end.
    The filing has a part on fines and penalties
    No
    The filing has a part on tax disputes
    No

    The company's own answers in its filing.

    How money raised was used

    Reported for the quarter to Mar 2025. The company's results filing for the quarter to Mar 2026 says no statement of how money raised was used applies to it.

    RaisedAmount raisedForSet asideSpentSpent elsewhere
    Public IssuesAug 202314.84Working Capital requirements8.988.98No
    Public IssuesAug 202314.84General Corporate Purpose3.663.66No
    Public IssuesAug 202314.84Issue Expenses2.202.20No
    ₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.